{"schema_version":"secwatch.filing_event.v1","accession":"0001808805-24-000043","form_type":"8-K","ticker":"NAUT","cik":"0001808805","company_name":"Nautilus Biotechnology, Inc.","filed_at":"2024-06-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.240186+00:00","generated_at":"2026-06-01T04:39:53.342116+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Nautilus Biotechnology announces 2024 annual meeting voting results","bullets":["Elected Melissa Epperly (92.1M for, 674K withheld), Matthew L. Posard (90.6M for, 2.1M withheld), Karen Akinsanya (89.9M for, 2.8M withheld) as Class III directors.","Ratified PricewaterhouseCoopers LLP as independent auditor for FY2024 with 105.1M votes for, 172.9K against, 69.2K abstentions.","Approximately 84% of outstanding shares (105.3M of 125.3M) represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001808805-24-000043","json":"https://secwatch.observer/filing/0001808805-24-000043.json","markdown":"https://secwatch.observer/filing/0001808805-24-000043.md","text":"https://secwatch.observer/filing/0001808805-24-000043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1808805/000180880524000043/0001808805-24-000043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1808805/000180880524000043/naut-20240613.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:39:53.342116+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}